Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

  • ID: 3746402
  • Report
  • Region: Canada
  • 71 pages
  • IMARC Group
1 of 3
Canada represents the world’s ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalyzed by a number of factors. The continuous expiration of drug patents, rising aging population, increasing prevalence of chronic diseases and constant efforts by the government and health care service providers to control their healthcare expenditures have enabled generics to represent a multibillion dollar industry in Canada.

The report entitled “Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.

Key Questions Answered:

What are generic drugs? How are they different from branded drugs?
How has the Canadian generic drug market performed in recent years?
How have generics performed compared to branded drugs?
What were the total sales and prescriptions for generic drugs in Canada?
Who are the key players in the Canadian generic drug market? How have they performed?
What is the structure of the generic drug market in Canada?
What is the pricing mechanism of generic drugs in Canada?
What is the value chain of generic drugs in Canada?
What are the regulations for generic drugs in Canada?
How are generic drugs distributed in Canada?
How are generic drugs manufactured?
What are the raw material and machinery requirements to manufacture generic drugs?
What are the drivers and challenges in the generic drug market in Canada?
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Research Methodology and Market Definitions
2 Report Summary
3 Canada Generic Drug Market - Introduction
3.1 What are Generics?
3.2 Unbranded and Branded Generics
3.3 Authorized Generics
3.4 Specialty Generics
4 Why is the Generic Drug Market so Lucrative in Canada
4.1 Blockbuster Drugs Facing Patent Expiration
4.2 Substantial Price Difference Between Branded and Generic Drugs
4.3 Government Incentives
4.4 Savings for Drug Purchasers
4.5 Biosimilars
4.6 Ageing Population and Increasing Prevalence of Life Style Diseases
5 Global Generic Drug Market
5.1 Current and Historical Market Trends
5.2 Market Breakup by Country
5.3 Market Forecast
5.4 Most Prescribed Generic and Branded Drugs
6 Canada Generic Drug Market
6.1 Canada Pharmaceutical Market – Current, Historical and Future Sales Trends
6.2 Canada Pharmaceutical Market – Current, Historical and Future Volume Trends
6.3 Canada Pharmaceutical Market - Share of Branded and Generic Drugs
6.4 Canada Generic Drug Market – Current, Historical and Future Sales Trends
6.5 Canada Generic Drug Market – Current, Historical and Future Volume Trends
7 Canada Generic Drug Market- Competitive Landscape
7.1 Canada Generic Drug Market - Competitive Structure
7.2 Canada Generic Drug Market - Sales Breakup of Key Players
7.3 Canada Generics Distribution – Breakup by Channel
7.4 Canada Generic Drug Market – Average Retail Price Per Prescription (Generic vs. Branded)
8 Canada Generic Drug Market - Value Chain Analysis
8.1 Research and Development
8.2 Manufacturing
8.3 Marketing
8.4 Distribution
9 Canada Generic Drug Market – Regulatory Framework
9.1 Overview of Pharmaceutical Regulations
9.2 Pre-Market Drug Submission Requirements for Generic Drugs
9.3 Review Process for Generic Drugs
9.4 Generic Drug Approval and Declaration of Its Bioequivalence
9.5 Other Important Considerations
10 Canada Generic Drug Market: Key Success Factors
11 Canada Generic Drug Market: Road Blocks
12 Requirements for Setting Up a Generic Drug Manufacturing Plant
12.1 Manufacturing Process
12.2 Raw Material Requirements
12.3 Machinery and Infrastructure Requirements
13 Canada Generic Drug Market - Key Company Profiles
13.1 Teva Pharmaceutical Ltd.
13.2 Apotex Inc.
13.3 Sandoz Canada
13.4 Actavis
13.5 Mylan
13.6 Pharmascience Inc.
13.7 Taro Pharmaceuticals
13.8 Novartis
13.9 Ranbaxy Pharmaceuticals Canada
13.10 Hospira
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll